Balyasny Asset Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-216,318
Closed -$70.4M 3251
2024
Q1
$70.4M Buy
216,318
+132,304
+157% +$32.5M 0.12% 207
2023
Q4
$16M Buy
+84,014
New +$15.9M 0.03% 693
2023
Q3
Sell
-48,346
Closed -$13.8M 2850
2023
Q2
$13.8M Sell
48,346
-54,525
-53% -$15.1M 0.03% 653
2023
Q1
$22.3M Buy
102,871
+70,265
+215% +$13.7M 0.06% 470
2022
Q4
$6.7M Buy
32,606
+31,760
+3,754% +$8.03M 0.02% 905
2022
Q3
$235K Buy
+846
New +$215K ﹤0.01% 2269
2021
Q4
Sell
-69,253
Closed -$14.3M 2670
2021
Q3
$14.3M Buy
69,253
+47,369
+216% +$9.3M 0.06% 442
2021
Q2
$4.15M Sell
21,884
-41,638
-66% -$6.81M 0.02% 774
2021
Q1
$8.27M Buy
+63,522
New +$7.62M 0.04% 545
2020
Q4
Sell
-43,383
Closed -$3.29M 1799
2020
Q3
$3.29M Sell
43,383
-225,106
-84% -$12.8M 0.02% 713
2020
Q2
$12.7M Buy
268,489
+31,042
+13% +$1.28M 0.11% 284
2020
Q1
$7.88M Sell
237,447
-122,172
-34% -$4.85M 0.09% 293
2019
Q4
$15.8M Buy
+359,619
New +$13.3M 0.09% 316

Other funds holding SWAV

Balyasny Asset Management's SWAV Position: Q2 2024 in Review

Balyasny Asset Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 216,318 shares — an estimated $70.4M sold.

Balyasny Asset Management first reported a position in SWAV in Q4 2019 and held it in 13 quarters. The position peaked at $70.4M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Balyasny Asset Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Balyasny Asset Management sold 216,318 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $70.4M.
  • Balyasny Asset Management first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2019 and held it in 13 quarters.
  • Balyasny Asset Management's Shockwave Medical, Inc. Common Stock position peaked at $70.4M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Balyasny Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.